1Division of Gastroenterology, Tohoku University Hospital, Sendai, Japan
2Clinical Research, Innovation and Education Center, Tohoku University Hospital, Sendai, Japan
3Graduate School of Public Health, Teikyo University, Tokyo, Japan
4Division of Gastroenterology, Iwate Prefectural Isawa Hospital, Oshu, Japan
5Division of Gastroenterology, Iwaki City Medical Center, Iwaki, Japan
© 2025 Korean Association for the Study of Intestinal Diseases.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Funding Source
The authors received no financial support for the research, authorship, and/or publication of this article.
Conflict of Interest
No potential conflict of interest relevant to this article was reported.
Data Availability Statement
Data are available upon reasonable request.
Author Contributions
Conceptualization: Moroi R, Nochioka K. Data curation: Moroi R. Formal analysis: Miyata S. Investigation: Moroi R, Iwaki H, Chiba H, Nagai H, Shimoyama Y, Naito T, Shiga H, Tosa M, Kakuta Y, Kayaba S, Takahashi S. Methodology: Moroi R, Nochioka K. Writing – original draft: Moroi R. Writing – review & editing: Kinouchi Y, Masamune A. Approval of final manuscript: all authors.
Additional Contributions
This study was supported by the Specified Clinical Trials Promotion Program of the Tohoku University Hospital. We thank Ms. Mizue Kusaba (Clinical Research, Innovation and Education Center, Tohoku University Hospital, Sendai, Japan) for her support in this study.
Adverse event | No. (%) |
---|---|
Delayed bleeding | 0 |
Perforation | 0 |
Worsening of CD | 1 (8.3) |
Variable | Resulta |
---|---|
Technical success rate of RIC (%) | 100 |
Procedure time of RIC (min), mean ± SD | 9.6 ± 6.4 |
Hospital stay after RIC (day), mean ± SD | 14.4 ± 7.5 |
Characteristic | Value (n = 10) |
---|---|
Male sex | 10 |
Age (yr) | 31.7 ± 8.2 |
Underlying disease, CD | 10 |
Duration of CD (yr) | 13.6 ± 11.0 |
Stenosis site (no. of lesions) | 10 |
Intestinal stricture (primary:secondary) | 3:7 |
Length of the stenosis, ≤ 1 cm | 10 |
Previous history of EBD | 3 |
Ulceration on the stenosis | 1 |
Administration of medication for CD | |
Infliximab | 4 |
Azathioprine | 3 |
5-Aminosalicylic acid | 2 |
Central parenteral nutrition | 1 |
Duration of follow-up after RIC (day) | 373 (318.5–595.3) |
Adverse event | No. (%) |
---|---|
Delayed bleeding | 0 |
Perforation | 0 |
Worsening of CD | 1 (8.3) |
Variable | Result |
---|---|
Technical success rate of RIC (%) | 100 |
Procedure time of RIC (min), mean ± SD | 9.6 ± 6.4 |
Hospital stay after RIC (day), mean ± SD | 14.4 ± 7.5 |
Values are presented as mean±SD or median (IQR). CD, Crohn's disease; EBD, endoscopic balloon dilation; RIC, radial incision and cutting; SD, standard deviation; IQR, interquartile range.
RIC, radial incision and cutting; CD, Crohn's disease.
Results from 10 participants, 10 lesions, and 12 sessions of RIC. RIC, radial incision and cutting; SD, standard deviation.